Status: current, Defined. Date: 30-Nov 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4252511000168112 | Mefenamic acid (MLPL) (mefenamic acid 250 mg) capsule, 50 capsules (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4252521000168117 | Mefenamic acid (MLPL) 250 mg capsule, 50 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mefenamic acid (MLPL) 250 mg capsule, 50 | Is a | mefenamic acid 250 mg capsule, 50 | true | Inferred relationship | Some | ||
| Mefenamic acid (MLPL) 250 mg capsule, 50 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Mefenamic acid (MLPL) 250 mg capsule, 50 | has TP | Mefenamic acid (MLPL) | true | Inferred relationship | Some | ||
| Mefenamic acid (MLPL) 250 mg capsule, 50 | has TPUU | Mefenamic acid (MLPL) 250 mg capsule | true | Inferred relationship | Some | 1266469475 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mefenamic acid (MLPL) 250 mg capsule, 50, bottle | Is a | True | Mefenamic acid (MLPL) 250 mg capsule, 50 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR